Objective: The purpose of this study was to formulate and evaluate the floating wax beads by the ionotropic gelation method.
Introduction
Development in the field of novel drug delivery is getting more attention, but still the oral route of administration is the most preferred route of administration as the physiology of the gastrointestinal tract offer more opportunities for the development of the dosage form. Thus the focus of the researcher is on the study of extended release of the drug with well controlled release profile (Dubey et al., 2013) . Retention of the dosage form in the gastric fluid increases the gastric transit time which ultimately increases the bioavailability of poorly soluble drugs (Patel et al., 2011) . These systems are suitable for the drugs that are absorbed from the stomach (Rao et al., 2016) .
There are different approaches based on their mechanism of release such floating, expansion/plug time, high density or adhesion to mucosa, low density (Singh et al., 2013) . Recently floating system has gained more attention because of increased gastric residence time. Immediate floating can be achieved either by the entrapment of the air (Krogel et al., 1999) or by the use of low density materials such as oils (Desai et al., 1993) or foam powders (Streuble et al., 2002) .
The floating wax microspheres were prepared by the ionotropic gelation method. The formation of microspheres occurs by the cross-linking of the calcium ions with pectin to form calcium pectinate. The morphology, floating properties, swelling studies, drug content, drug entrapment efficiency and drug release study was carried out. The purpose of the present study was to investigate the influence of incorporated wax, which prepared by the ionotropic gelation technique on the drug release profile.
Materials and methods

Materials
Tizanidine hydrochloride was received as generous gift from Blue Cross Laboratories Pvt. Ltd. Nasik. Pectin, olive oil, carnauba wax, Calcium chloride used were of laboratory grade and available at institute.
Preparation of floating wax microspheres
The emulsion of pectin, olive oil and Tizanidine hydrochloride was prepared in distilled water using a high speed homogenizer (IKA T25) at 3000 rpm. The weighed amount of the wax was melted on the water bath at the temperature of more than 5 C of melting point of the wax. The molten wax was dispersed in the previously heated homogenized emulsion of pectin, olive oil and Tizanidine hydrochloride and mixed until the homogeneous mixture was obtained. The hot melted mixture was extruded in the 2% w/v Calcium chloride solution through 22G syringe. The microspheres formed were allowed to remain in the calcium chloride solution for 10 -20 mins for the hardening of the microspheres. The microspheres formed were then filtered and washed thoroughly with water to remove the excess of calcium from the surface of the microspheres (Pornsak et al., 2008) .
Micromeritic properties
All the prepared formulations of floating microspheres were evaluated for bulk density, tapped density, Carr's index and Hausner's ratio (Patel et al., 2009; USP-2008) .
Percentage yield
All the prepared formulations of floating microspheres were evaluated for the percentage yield by using following formula (Patel et al.,2009; Tekde et al.,2009 ):
Determination of drug content and drug entrapment efficiency
The 50mg of floating microspheres was dissolved in 0.1 N Hydrochloric acid under sonication and filtered. The drug content was assayed using UV-spectrophotometer (V -630, Shimadzu Co Ltd., Japan) at 228 nm after suitable dilution with 0.1 N Hydrochloric acid. Percent drug content and entrapment efficiency was determined using formula (Yadav et al., 2014) : 
Swelling studies
Microspheres were studied for swelling characteristics. Only those batches were selected which have good drug content and entrapment efficiency more than 50%. Sample from drug loaded microspheres were taken, weighed and placed in wire basket of USP dissolution apparatus II. The basket containing microspheres put in a beaker containing 100 ml of 0.1N HCl (pH1.2) maintained at 37 c. The 0 microspheres were periodically removed at predetermined intervals and weighed. Then swelling ratio was calculated as per the following formula (Gareeb et al., 2014) :
Where, Ws = weight of swollen microspheres, Wo = weight of dried microspheres
Particle size determination
The particle size of microspheres was determined by the dry state using optical microscopy method. The stage micrometer and eyepiece micrometer were used for the measurement of the particle size. The size of the microspheres present in the 1cm area of the slide was 3 counted (Fursale et al., 2009) .
Surface characterization
Surface characterization of microspheres was examined with a scanning Electron Microscopy (SEM Sophisticated Test and Instrumentation centre, Cochin). Microspheres were mounted on metal grids using double-sided tape and coated with gold under vacuum (Khan et al., 2011) .
Differential Scanning Calorimetry (DSC)
The DSC measurements were performed on a DSC 60, Shimadzu, Japan differential scanning calorimeter with thermal analyzer. All accurately weighed samples were deposited in a sealed aluminum pans, before heating under nitrogen flow (10 ml/min) at a scanning rate of 10 C per 0 min from 25 to 300 C. An empty aluminum pan was used as 0 www.ajpp.in Asian Journal of Pharmacy and Pharmacology 2018; 4(5): 673-679reference (Patel et al., 2009; Gupta et al., 2013) .
Fourier Transform Infrared Spectroscopy (FTIR)
The compatibility study was carried out using Fourier transform infrared spectrophotometer (BRUKER -ECO ATR). FTIR study was carried out on pure drug and physical mixture of drug and polymer. Physical mixtures were prepared and samples were kept for 1 month at room temperature. Infrared absorption spectrum of Tizanidine hydrochloride and physical mixture was recorded over the wave number 4000 to 400 cm using Fourier -1
Transform spectrophotometer (Bruker, ECO-ATR) (IP-2014; Srivastav 2012; Pavia et al., 2007) .
In-vitro drug release study
The release of Tizanidine hydrochloride from sustained release floating wax microspheres was determined using USP dissolution apparatus II at 50 rpm. The dissolution medium used was 900 ml of 0.1N HCl (pH1.2) and temperature was maintained at 37 C. A sample (5ml) was withdrawn from the 0 dissolution apparatus at 0 min., 1hr, 2hr, 4hr, 6hr, 8hr, 10hr, 12hr. The samples were filtered through whatman filter paper and analysed using UV method. Cumulative % drug release was calculated and observed. The dissolution of the formulation was compared with the 250mg of the capsule containing 4mg of the drug (Pornsak et al., 2008) .
Best fit kinetic model for optimized formulation
The data obtained from study of diffusion kinetics of the optimized formulation was studied to obtain the best fit model. The best fitted model is the one which gives the highest R value 2 and least slope value.
Stability study
Stability study of the formulation which gave maximum dissolution rate was carried out to point out any visual physical or chemical change made in the formulation after storing it at elevated temperature and humidity conditions. The optimized formulation was store in ambient colour bottle and stored at 40 C 0 ± 2 C and 75% ± 5% Relative humidity for three months. 
Statistical Analysis
Results of ex-vivo experiments are reported as SEM analysis. The classical zero order release curve was found to be linear. The curves plotted according to first order and Higuchi model were also found to be linear. For the Korsemeyer-Peppas release curves R was found to be 0.886 for all 4 2 ≥ formulations. The drug release occurs probably by diffusion and erosion and dissolution. From the above tables it was seen that the best fit model for formulation was Zero order kinetic, such type of model was applicable when sustained release dissolution mechanism are seen.
Results and discussion
Micromeritic properties
From the study of the micromeritic properties of the formulation it was found that the bulk density of the formulation lies within range of 0.3614 -0.4734 g/cm , 3 tapped density within range of 0.3849-0.5036. The Carr's index lies within range of 5.99 -8.22 and Hausner's ratio within range of 1.0270 -1.0834 which indicates that the prepared formulation have excellent flow property (Table 1) .
Percentage yield
All formulations F1 -F4 showed percentage yield 97.79 -99.26% which lied in the normal range (Table 2) .
Drug content and drug entrapment efficiency
The percentage drug content of all prepared formulations was found to be in the range of 92.56 -98.77%. Therefore uniformity of drug content was maintained in all formulations ( Table 2 ).
The percentage drug entrapment efficiency of all prepared formulations was found to be in the range of 90.28% -92.62%. Therefore entrapment efficiency was found to be less due to the diffusion of the drug into the calcium chloride solution during the formation of the microspheres (Table 2) .
Floating lag time and floating time
Floating lag time in the range of 1.18 -3.28 min. and floating time >12hr for all formulations F1-F4. This is due the increase in the concentration of the carnauba wax (Table 3) .
Swelling studies
For all prepared batches (F1-F4), percent swelling ratio was found to be in the range of 8.92 -19.04 % from table 6. The www.ajpp.in
Batch code
Bulk density (gm/ml) ± SD Tapped density (gm/ml) ± SD Carr's index ±SD Hausner's ratio ± SD F1 batch showed the maximum swelling index. This is because of the lipohillic nature of the carnauba wax which affected the swelling of the microspheres (Table 4) .
Particle size determination
For F1-F4 batches average particle size was found to be in the range of 1.21 -1.52 mm (Table 4) .
Surface characterization
The SEM result showed that the particle size of formulation was found to have regular and spherical shape with rough and uneven surface (Figure 1) .
Differential scanning calorimetric studies
Tizanidine Hydrochloride was compatible with polymer. There is slightly peak broadening in physical mixture of polymer to pure Tizanidine Hydrochloride ( Figure 2 ).
Fourier transform infrared spectroscopy
FTIR spectrum of the physical mixture shows that there is no interaction between drug and polymer (Figure 3) .
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In vitro drug release
Maximum drug release 94.60% was shown by F2 batch. The data also suggested that floating microspheres formulation were capable to produce linear drug release for longer period of time. Drug release profile of formulation F1 to F4 and dissolution profile F1 to F4 signified sustained drug release. Out of four formulations maximum release after 12 hr was found for F2 formulation (Table 5 and Figure 4 ).
From the comparative study of the formulation with capsule containing the dose of 4mg of Tizanidine hydrochloride, it was found that the capsule containing drug showed the 98.49% drug release within 6 hrs while the prepared formulation (F2 Batch) showed maximum drug release up to 94.60% within 12 hrs (Table 6 and Figure 5 ).
Kinetic model for F2 batch
In order to investigate the mode of release from floating microspheres data were analysed with following mathematical model.
A. Zero order kinetic
B. First order kinetic
C. Higuchi equation
D. Korsemeyer-peppas equation
The classical zero order release curve was found to be linear. The curves plotted according to first order and Higuchi model were also found to be linear. For the Korsemeyer-Peppas release curves R was found to be 0.886 for all 4 2 ≥ formulations. The drug release occurs probably by diffusion and erosion and dissolution. From the table it was seen that the best fit model for formulation was Zero order kinetic, such type of model was applicable when sustained release dissolution mechanism are seen (Table 7 and Figure 6 : (A),(B),(C) and (D) ). Table 7 . Drug release by using different models by F2 batch
Stability study
The sample were withdrawn after 1, 2 and 3 months and subjected to following tests a shown in. The accelerated stability studies (carried for 3 months), at temperature of 40 C 0 ± 2 C and % RH 75% ± 5% RH indicated that the developed 0 floating pectinate microspheres were unaffected after 03 months storage under accelerated condition as no change was observed in the appearance and colour of the formulation. On the basis of these results, it may be concluded that the F2 formulation developed is stable under accelerated condition of 03 months (Table 8) .
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